REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Innovent Biologics, Inc. (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Innovent Biologics, Inc. Profile Updated: July 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Innovent Biologics, Inc. is a biopharmaceutical company. It develops and commercializes drugs. The company was founded in 2011 and is headquartered in Suzhou City, China.

Headquarters
168 Dongping Street, Suzhou Industrial Park
Suzhou; Jiangsu; Postal Code: 215123

Contact Details: Purchase the Innovent Biologics, Inc. report to view the information.

Website: http://www.innoventbio.com

Basic Information
Total Employees:
Purchase the Innovent Biologics, Inc. report to view the information.
Outstanding Shares:
Purchase the Innovent Biologics, Inc. report to view the information.
Registered Capital:
Purchase the Innovent Biologics, Inc. report to view the information.
Financial Auditors:
Purchase the Innovent Biologics, Inc. report to view the information.
Incorporation Date:
April 28, 2011
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Innovent Biologics (Hk) Limited
100%
Innovent Biologics International Inc (United Kingdom)
100%
Innovent Biopharmaceuticals Inc. (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Innovent Biologics, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
46.3%▲
Total operating revenue
44.95%▲
Operating profit (EBIT)
4.98%▲
EBITDA
N/A
Net Profit (Loss) for the Period
-182.16%▼
Total assets
13.4%▲
Total equity
15.24%▲
Operating Profit Margin (ROS)
6.32%▲
Net Profit Margin
-4.78%▼
Return on Equity (ROE)
-1.87%▼
Debt to Equity Ratio
-4.9%▼
Quick Ratio
-1%▼
Cash Ratio
-0.69%▼

Similar companies

China Resources Pharmaceutical Group Ltd
 
Fosun International Limited
CSPC Pharmaceutical Group Limited
 
Sino Biopharmaceutical Limited
China Traditional Chinese Medicine Holdings Co. Limited
 
United Laboratories International Holdings Limited
SSY Group Limited
 
HUTCHMED China Limited
China Shineway Pharmaceutical Group Limited
 
Akeso, Inc. (Zhongshan) (康方生物科技开曼有限公司 (中山))
SciClone Pharmaceuticals (Holdings) Limited
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo